21 CFR Encyclopedia → 21 CFR 211.63
21 CFR 211.63
Drugs
81 Annual Form 483 Citations
21 CFR 211.63 — Equipment Design, Size and Location
Plain-English Risk Theme: Cleaning Validation, Sanitation Logs & Pest Control · Official eCFR Text ↗
Official FDA Inspectional Observation Template
"Equipment used in the manufacture, processing, packing or holding of drug products is not [of appropriate design] [of adequate size] [suitably located] to facilitate operations for its [intended use] [cleaning and maintenance]. Specifically, ***"
Plain-English Brand & QA Translation
Incomplete equipment cleaning/sanitation logs, inadequate allergen or cross-contamination changeover validation, or gaps in facility pest exclusion.
🚨 Why 15-Day Form 483 Responses Fail on 21 CFR 211.63:
FDA routinely rejects 15-day Form 483 responses for 21 CFR 211.63 when a facility merely states 'we revised our SOP and retrained personnel' without attaching: (1) the signed, effective-dated SOP, (2) photographic or batch-log proof of implementation, and (3) a retrospective impact assessment of all commercial lots manufactured over the prior 24 months within expiry.
✅ Standard 15-Day CAPA Remediation Blueprint:
- Immediate Containment (Days 1–3): Place affected raw materials or in-process lots on QA Hold and open formal CAPA under 21 CFR 211.63.
- Systemic Root-Cause & SOP Overhaul (Days 4–10): Implement lot-linked equipment cleaning verification logs with QA sign-off before line clearance, ATP/allergen swabbing after shared-line runs, and weekly documented pest-control inspections.
- Retrospective Lot Review & Effectiveness Check (Days 11–15): Test retention samples of distributed lots and schedule a 30/60/90-day QA audit to prove sustained compliance.
Copy-Paste Compliant SOP Clause Template (21 CFR 211.63)
FREE AUDIT-READY BOILERPLATESTANDARD OPERATING PROCEDURE — COMPLIANCE CLAUSE 21 CFR 211.63 1. PURPOSE: Establish mandatory cGMP controls satisfying 21 CFR 211.63 (Equipment Design, Size and Location). 2. REQUIREMENT: Implement lot-linked equipment cleaning verification logs with QA sign-off before line clearance, ATP/allergen swabbing after shared-line runs, and weekly documented pest-control inspections. 3. QA VERIFICATION & SIGN-OFF: Dual independent verification by Production and Quality Assurance Unit (QAU) is required prior to batch release. Any deviation or Out-of-Specification (OOS) result triggers a formal CAPA investigation within 24 hours.
FDA Investigators Who Frequently Cite 21 CFR 211.63
Published Form 483s Citing 21 CFR 211.63
RC Outsourcing LLC
Issued 2026-09-03
Read 483 Breakdown →
Houston Rx LLC
Issued 2026-08-28
Read 483 Breakdown →